Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06990503 | SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer | not yet recruiting | Phase 3 | 300 | Tongji HospitalOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT06990516 | SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer | not yet recruiting | Phase 1 / Phase 2 | 90 | Tongji HospitalOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT06990971 |
| not yet recruiting |
| — |
| 200 |
| Cycle Therapeutics LtdINDUSTRY |
| 0 |
| May 25, 2025 |
| clinicaltrials |
| NCT06986057 | Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer | not yet recruiting | Phase 2 | 28 | Shandong Tumor HospitalOTHER | 0 | May 22, 2025 | clinicaltrials |
| NCT06981858 | A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 34 | Chongqing University Cancer HospitalOTHER | 0 | May 21, 2025 | clinicaltrials |
| NCT06982690 | Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial | not yet recruiting | N/A | 370 | National Taiwan University HospitalOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06981182 | EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults(EQUITA) | not yet recruiting | N/A | 300 | University of SunderlandOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06974539 | TULIP ReTrain Study(TULIP ReTrain) | not yet recruiting | N/A | 212 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT06976021 | Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy(INTROSPECTION) | not yet recruiting | Phase 2 | 60 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 0 | May 16, 2025 | clinicaltrials |
| NCT06973421 | Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer | not yet recruiting | Phase 2 | 35 | Fudan UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06966089 | ExosomeDx in MRI-negative Men With High PSA | not yet recruiting | N/A | 425 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT06960174 | Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer Surgery | not yet recruiting | N/A | 70 | St. Antonius HospitalOTHER | 0 | May 7, 2025 | clinicaltrials |
| NCT06957561 | Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer(DIVON) | not yet recruiting | Phase 1 / Phase 2 | 30 | Sun Yat-sen UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT06950216 | IONM During Radical Prostatectomy | not yet recruiting | N/A | 40 | The Fourth Affiliated Hospital of Zhejiang University School of MedicineOTHER | 0 | Apr 30, 2025 | clinicaltrials |
| NCT06945601 | The Effect of Previous Pregnancies in Patients With Gynecological Neoplasms Treated With PD-1/PD-L1 Inhibitors(FECONDE) | not yet recruiting | — | 150 | IRCCS San RaffaeleOTHER | 0 | Apr 25, 2025 | clinicaltrials |
| NCT06870279 | A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC | not yet recruiting | Phase 1 | 28 | RenJi HospitalOTHER | 0 | Apr 24, 2025 | clinicaltrials |
| NCT06931496 | Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy(PROSTIA- BP) | not yet recruiting | N/A | 150 | Central Hospital, Nancy, FranceOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06929234 | Effects of Health Education on Knowledge, Attitude and Screening for Cervical Cancer in Women | not yet recruiting | N/A | 30 | Ordu UniversityOTHER | 0 | Apr 16, 2025 | clinicaltrials |
| NCT06922903 | Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. | not yet recruiting | Phase 3 | 240 | Yunhe Pharmaceutical (Tianjin) Co., LtdOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT06925126 | Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer | not yet recruiting | — | 200 | Fudan UniversityOTHER | 0 | Apr 13, 2025 | clinicaltrials |
| NCT06921798 | Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program | not yet recruiting | N/A | 3,000 | University of VirginiaOTHER | 0 | Apr 10, 2025 | clinicaltrials |
| NCT06912672 | Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma(UMT-UC) | not yet recruiting | — | 1,500 | Shanghai Epiprobe Biotechnology Co., Ltd.INDUSTRY | 0 | Apr 8, 2025 | clinicaltrials |
| NCT06916013 | Focal Laser Ablation in Prostate Cancer | not yet recruiting | — | 30 | Ain Shams UniversityOTHER | 0 | Apr 8, 2025 | clinicaltrials |
| NCT06916117 | Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC | not yet recruiting | Phase 2 | 30 | RenJi HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06911801 | In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer(FAPI_VULVA_1) | not yet recruiting | — | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06828419 | A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery | not yet recruiting | N/A | 63 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06901778 | Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation | not yet recruiting | N/A | 106 | Peking University People's HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT05896371 | A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy(PRODIGY-1) | not yet recruiting | Phase 1 / Phase 2 | 500 | CHU de Quebec-Universite LavalOTHER | 0 | Mar 30, 2025 | clinicaltrials |
| NCT06900348 | Prostate Specific Antigen Levels of Individuals Living in Rural Areas | not yet recruiting | — | 308 | Suleyman Demirel UniversityOTHER | 0 | Mar 30, 2025 | clinicaltrials |
| NCT06901492 | The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture | not yet recruiting | N/A | 120 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT06882447 | A Study of QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer(QL1706) | not yet recruiting | Phase 2 | 35 | Northern Jiangsu People's HospitalOTHER | 0 | Mar 28, 2025 | clinicaltrials |
| NCT06890832 | A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer | not yet recruiting | Phase 2 | 75 | Jina Pharmaceuticals Inc.INDUSTRY | 0 | Mar 24, 2025 | clinicaltrials |
| NCT06875297 | A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients | not yet recruiting | N/A | 184 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06887673 | Lipid Mediators & Cancer: Montelukast, SPM, and Almonds | not yet recruiting | Early Phase 1 | 56 | University of South FloridaOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06882473 | A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer | not yet recruiting | N/A | 20 | Peking University Third HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06870565 | Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma | not yet recruiting | Phase 3 | 238 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | Mar 17, 2025 | clinicaltrials |
| NCT06871787 | Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery(INOCA) | not yet recruiting | Phase 4 | 50 | Istanbul UniversityOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06866392 | Study on Novel Strategies for Cervical Cancer Screening Using Photoelectric Detection and Epigenetic Procotol(CC-AZ) | not yet recruiting | — | 4,200 | Peking Union Medical College HospitalOTHER | 0 | Mar 10, 2025 | clinicaltrials |
| NCT06866795 | Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC) | not yet recruiting | Phase 1 | 42 | Geode Therapeutics Inc.INDUSTRY | 0 | Mar 10, 2025 | clinicaltrials |
| NCT06859151 | DNA Methylation and the Increased Risk of Cervical Cancer Development | not yet recruiting | — | 2,000 | Zhujiang HospitalOTHER | 0 | Mar 5, 2025 | clinicaltrials |
| NCT06855589 | Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.(PCS-XII) | not yet recruiting | Phase 3 | 400 | Charles LeMoyne HospitalOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06846424 | SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer | not yet recruiting | Phase 1 | 24 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06844513 | Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform(URO-ROBOT-2023) | not yet recruiting | N/A | 800 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06364904 | A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma. | not yet recruiting | Phase 3 | 210 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06838429 | PARPi and Ovarian Cancer Survival | not yet recruiting | — | 6,000 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 0 | Feb 20, 2025 | clinicaltrials |
| NCT06838520 | Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer | not yet recruiting | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06832397 | Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical Carcinoma(SOLAR) | not yet recruiting | — | 120 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06827080 | Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 / Phase 2 | 15 | Zhengguo ChenOTHER | 0 | Feb 14, 2025 | clinicaltrials |
| NCT06828003 | Feasibility of a Remotely-Delivered Resistance Training Program for Cognitive Function in Men Living With and Beyond Prostate Cancer | not yet recruiting | N/A | 30 | University of TorontoOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06825455 | Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 18 | Peking UniversityOTHER | 1 | Feb 13, 2025 | clinicaltrials |
Data updated 23 days agoSource updated May 25, 2025source: clinicaltrials